Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 21.25
0.00 (0.00%)
At close: Dec 29, 2025
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.57 billion as of December 30, 2025. Its market cap has increased by 16.97% in one year.
Market Cap
1.57B
Enterprise Value
1.89B
Revenue
918.75M
Ranking
n/a
PE Ratio
18.29
Stock Price
€21.25
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.57B, an increase of 402.10%. That is a compound annual growth rate of 9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.57B | 28.27% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | 1.38B | -1.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.92B |
| argenx SE | 43.79B |
| Financière de Tubize | 9.33B |
| Ion Beam Applications | 371.69M |
| Onward Medical | 196.62M |
| Nyxoah | 177.27M |
| Hyloris Pharmaceuticals | 156.80M |
| Sequana Medical NV | 37.03M |